ArticleBlood cancer journal2021

HSP90 inhibitor NVP-BEP800 affects stability of SRC kinases and growth of T-cell and B-cell acute lymphoblastic leukemias.

Rony Mshaik et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.